Sunshine Biopharma Inc - ESG Rating & Company Profile powered by AI
Comprehensive ESG analysis of Sunshine Biopharma Inc can be reached by registering for free. This analysis of Sunshine Biopharma Inc is prepared by All Street Sevva using proprietary machine learning. Check the end of the webpage for potential risks for Sunshine Biopharma Inc based on industry, location and marketcap.
Sunshine Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 2.7, social score of 4.8 and governance score of 6.0.
4.5
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
852 | Vaccibody AS | 4.6 | High |
852 | argenx SE | 4.6 | High |
868 | Sunshine Biopharma Inc | 4.5 | High |
868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
868 | Boiron SA | 4.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sunshine Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Does Sunshine Biopharma Inc disclose current and historical energy intensity?
Does Sunshine Biopharma Inc report the average age of the workforce?
Does Sunshine Biopharma Inc reference operational or capital allocation in relation to climate change?
Does Sunshine Biopharma Inc disclose its ethnicity pay gap?
Does Sunshine Biopharma Inc disclose cybersecurity risks?
Does Sunshine Biopharma Inc offer flexible work?
Does Sunshine Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sunshine Biopharma Inc disclose the number of employees in R&D functions?
Does Sunshine Biopharma Inc conduct supply chain audits?
Does Sunshine Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sunshine Biopharma Inc conduct 360 degree staff reviews?
Does Sunshine Biopharma Inc disclose the individual responsible for D&I?
Does Sunshine Biopharma Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sunshine Biopharma Inc disclose current and / or historical scope 2 emissions?
Does Sunshine Biopharma Inc disclose water use targets?
Does Sunshine Biopharma Inc have careers partnerships with academic institutions?
Did Sunshine Biopharma Inc have a product recall in the last two years?
Does Sunshine Biopharma Inc disclose incidents of discrimination?
Does Sunshine Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Has Sunshine Biopharma Inc issued a profit warning in the past 24 months?
Does Sunshine Biopharma Inc disclose parental leave metrics?
Does Sunshine Biopharma Inc disclose climate scenario or pathway analysis?
Does Sunshine Biopharma Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sunshine Biopharma Inc disclose the pay ratio of women to men?
Does Sunshine Biopharma Inc support suppliers with sustainability related research and development?
Does Sunshine Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sunshine Biopharma Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sunshine Biopharma Inc involved in embryonic stem cell research?
Does Sunshine Biopharma Inc disclose GHG and Air Emissions intensity?
Does Sunshine Biopharma Inc disclose its waste policy?
Does Sunshine Biopharma Inc report according to TCFD requirements?
Does Sunshine Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sunshine Biopharma Inc disclose energy use targets?
Does Sunshine Biopharma Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sunshine Biopharma Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Sunshine Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.